InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Who will benefit from a single European court system?


Although the unitary patent court is to be split between three jurisdictions, local lawyers there won’t necessarily be the ones to win the new work. Ben Naylor explains

After almost 40 years of negotiations, the unitary patent system is close to being realised with the final step, the ratification of the agreement by the parliaments of at least 13 of the 25 participating EU member states, expected later...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

"The recent proposal of automatically granting pending applications without examination is nothing but a desperate… https://t.co/9lE4RD00Rz

Nov 20 2017 09:17 ·  reply ·  retweet ·  favourite
ManagingIP profile

New speakers announced at our NY https://t.co/sCxge69xRz and CA https://t.co/BGVnkVWSpC European Patent Events. F… https://t.co/3MlekFfPZR

Nov 20 2017 03:33 ·  reply ·  retweet ·  favourite
ManagingIP profile

India’s Supreme Court pushes for faster IPR suits https://t.co/G0vmxWOc5g Delhi High Court has been given until mid… https://t.co/W576LiUGCF

Nov 20 2017 10:05 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


null null null

null null null

October 2017

Courts grapple with scope of patent protection

The Supreme Court’s decision in Actavis v Eli Lilly introduced a doctrine of equivalents and arguably also established a doctrine of prosecution history estoppel in the UK. We look at the law across Europe, and the impact the decision might have. Kingsley Egbuonu, Michael Loney and James Nurton set the scene



Most read articles

Supplements